The cluster is too small relative to market cap to be a meaningful bearish signal. However, the concentration of C-suite selling near the $320+ level suggests insiders may view the current valuation as full. Monitor for any 8-K filings or earnings pre-announcements in the next 30 days that could explain the timing. The stock's 87% analyst bullish rating and strong institutional ownership (JPMorgan $3.5B, BlackRock $3.0B) provide a counterweight.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 17 $314.18entry
- T+1 · 3mo ago −0.79%α −0.12% · $311.69
- T+5 · 3mo ago +4.31%α +5.50% · $327.72
- T+20 · 2mo ago +11.65%α +13.63% · $350.78
- T+60 · 7d ago −0.70%α +2.24% · $311.98
Price Chart
How similar events traded
Executive Summary
Seven Natera insiders, including the CEO, CFO, Executive Chairman, and President of Clinical Diagnostics, sold a total of $3.4M in shares over a one-week window. While the dollar amount is modest relative to Natera's $44.8B market cap (0.008%), the cluster includes multiple C-suite executives selling near the stock's highs, which warrants attention. The sales appear to be a mix of routine tax-withholding dispositions and open-market sales, with no clear 10b5-1 pattern, reducing the bearish signal strength.
Key Financial Metrics
Key Facts
- Seven insiders sold shares totaling $3.4M between Aug 3-10, 2026
- Executive Chairman Matthew Rabinowitz sold $642K at $320.90
- Director Jonathan Sheena sold $1.95M at $325.32
- CEO Steven Chapman sold $178K at $263.86
- CFO Michael Brophy sold $131K at $274.22
- Total sales represent ~0.008% of Natera's $44.8B market cap
- No single insider sold more than 0.004% of their likely holdings
Financial Impact
Total insider sales of $3.4M, or 0.008% of market cap, trivial relative to company size
Risk Factors
- Insiders selling near all-time highs could indicate peak valuation concerns
- No 10b5-1 plans disclosed for the largest sales, raising timing questions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1786757758067 |
Track record
63 reports on NTRA
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $319.09 +6.21% settles Nov 17
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $319.09 −0.23% ▲ +0.98% +1.33% vs SPY
- Nov 10, 20266d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $319.09 −0.23% ▲ +0.98% +1.33% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $319.09 +2.71% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $319.09 +2.71% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $319.09 −12.28% ▼ −14.59% −14.91% vs SPY
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $319.09 −12.28% ▼ −14.59% −14.91% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $319.09 −18.40% ▼ −6.97% −2.56% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $319.09 −17.89% ▲ +0.62% −1.03% vs SPY
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $319.09 −17.89% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers